AC Immune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.

About ACIU

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. 

CEO
Andrea Pfeifer
CEOAndrea Pfeifer
Employees
172
Employees172
Headquarters
Lausanne, Vaud
HeadquartersLausanne, Vaud
Founded
2003
Founded2003
Employees
172
Employees172

ACIU Key Statistics

Market cap
194.14M
Market cap194.14M
Price-Earnings ratio
-3.41
Price-Earnings ratio-3.41
Dividend yield
Dividend yield
Average volume
143.63K
Average volume143.63K
High today
$2.08
High today$2.08
Low today
$1.65
Low today$1.65
Open price
$2.03
Open price$2.03
Volume
293.83K
Volume293.83K
52 Week high
$4.26
52 Week high$4.26
52 Week low
$1.43
52 Week low$1.43

People also own

Based on the portfolios of people who own ACIU. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.